Header cover image

German Pharmaceuticals & Biotech Inefficient Market Opportunities

UPDATED May 18, 2022

Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
C1PConsun Pharmaceutical Group€0.510%-10.6%€3.4b€1.06PS4.9xE10.3%6.6%
X0M1XOMA€16.40-1.8%-33.9%€203.0m€57.68PS16.9xE58.1%n/a
Page 1 of 1